"Graham Health System consists of Graham Hospital in Canton, five medical Group Clinics: Canton, Elmwood, Farmington, Lewiston and Williamsfield, and Graham Home Medical Equipment and The Graham Wellness Center."

During the past decade, Graham Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 130 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 25 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Graham Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 75 trials, followed by "National Cancer Institute (NCI)" with 62 trials sponsored, "SWOG Cancer Research Network" with 15 trials sponsored, "Eastern Cooperative Oncology Group" with 14 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 14 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Graham Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 134 trials as a collaborator, "NCIC Clinical Trials Group" with 15 trials as a collaborator, "Cancer and Leukemia Group B" with 12 trials as a collaborator, "Eastern Cooperative Oncology Group" with 11 trials as a collaborator and "NRG Oncology" with 11 trials as a collaborator. Other collaborators include 32 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Graham Hospital" are "Breast Cancer" (29 trials), "Lung Cancer" (18 trials), "Lymphoma" (17 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (12 trials) and "Colorectal Cancer" (7 trials). Many other conditions were trialed in "Graham Hospital" in a lesser frequency.

Most popular intervention types in "Graham Hospital" are "Drug" (168 trials), "Other" (80 trials), "Biological" (79 trials), "Radiation" (34 trials) and "Procedure" (17 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (41 trials), "placebo" (23 trials), "Bevacizumab" (17 trials), "Paclitaxel" (16 trials) and "carboplatin" (16 trials). Other intervention names were less common.

The vast majority of trials in "Graham Hospital" are 154 trials for "All" genders, 36 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Graham Hospital". undefined are not yet recruiting, undefined are recruiting, 39 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 140 completed trials in Graham Hospital, undefined suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in Graham Hospital, 12 "Phase 1" clinical trials were conducted, 93 "Phase 2" clinical trials and 93 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".